Literature DB >> 34052215

HUMAN LATERALITY DISORDERS: PATHOGENESIS, CLINICAL MANIFESTATIONS, DIAGNOSIS, AND MANAGEMENT.

Muhammad Soofi1, Martin A Alpert2, Jennifer Barbadora3, Basanti Mukerji4, Vaskar Mukerji5.   

Abstract

Human laterality disorders comprise a group of diseases characterized by abnormal location (situs) and orientation of thoraco-abdominal organs and vessels across the left-right axis. Situs inversus totalis is mirror image reversal of thoraco-abdominal organs/great vessels. Situs ambiguus, better known as heterotaxy, is abnormal arrangement of thoraco-abdominal organs across the left-right axis excluding situs inversus totalis. Heterotaxy, also referred to as atrial or atrial appendage isomerism, is characterized by abnormal location of left-sided or right-sided organs with loss of asymmetry of normally paired asymmetric organs. It is associated with a variety of anomalies involving the heart, great vessels, lungs and intra-abdominal organs. Right and left atrial isomerism are associated with multiple complex congenital cardiac and vascular anomalies, many of which are lethal when untreated. Isomerism may also affect the lungs, spleen, liver, gall bladder, and intestines. Innovative surgical therapy of heterotaxy/isomerism has reduced early mortality and markedly improved long-term prognosis.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  Atrial Isomerism; Congenital Heart Disease; Heterotaxy; Human Laterality Disorders; Situs Ambiguus

Year:  2021        PMID: 34052215     DOI: 10.1016/j.amjms.2021.05.020

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  1 in total

1.  De novo disruptive heterozygous MMP21 variants are potential predisposing genetic risk factors in Chinese Han heterotaxy children.

Authors:  Xi-Ji Qin; Meng-Meng Xu; Jia-Jun Ye; Yi-Wei Niu; Yu-Rong Wu; Rang Xu; Fen Li; Qi-Hua Fu; Sun Chen; Kun Sun; Yue-Juan Xu
Journal:  Hum Genomics       Date:  2022-09-19       Impact factor: 6.481

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.